Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Capital/Financing Update 2011

Dec 11, 2011

65640_rns_2011-12-11_4cecf41b-ad51-4286-8dab-70aff2635fbe.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

$\sim$ 100

MARKET RELEASE

12 December 2011

Phylogica Limited

TRADING HALT

The securities of Phylogica Limited (the "Company") will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Wednesday 14 December 2011 or when the announcement is released to the market.

Security Code: PYC

$\overline{1}$

PYCOA

Kerrie Papamihail Assistant Manager, Listings (Perth) 12.DEC.2011 $7:14$

PHYLOGICA

BEYOND ANTIBODIES

09 December 2011

Ms Tonia Oliviera Issuers Adviser Australian Securities Exchange Exchange Plaza 2 The Esplanade PERTH WA 6000 By Facsimile: 9221 2020

Dear Tonia Trading Halt

Phylogica Limited ACN 098 391 961 (Company) (ASX Codes: PYC / PYCOA) requests an immediate trading halt be placed on its securities pending an announcement regarding a proposed capital raising.

Phylogica can see no reason why a trading halt should not be granted. The Company's securities are to remain in the trading halt until the earlier of the commencement of normal trading on 14 December 2011 or when the announcement regarding the proposed capital raising is released to the market. Regards

Nick Wooff Chief Financial Officer

PO Box 8207, Subiaco East, Western Australia 6008 Tel: +61 8 9384 3284 Fax: +61 8 9284 3801 www.phylogica.com ABN 48 098 391 981